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Abstract The lipid kinase VPS34 orchestrates diverse processes, including autophagy, endocytic
sorting, phagocytosis, anabolic responses and cell division. VPS34 forms various complexes that
help adapt it to specific pathways, with complexes I and II being the most prominent ones. We
found that physicochemical properties of membranes strongly modulate VPS34 activity. Greater
unsaturation of both substrate and non-substrate lipids, negative charge and curvature activate
VPS34 complexes, adapting them to their cellular compartments. Hydrogen/deuterium exchange
mass spectrometry (HDX-MS) of complexes I and II on membranes elucidated structural
determinants that enable them to bind membranes. Among these are the Barkor/ATG14L
autophagosome targeting sequence (BATS), which makes autophagy-specific complex I more active
than the endocytic complex II, and the Beclin1 BARA domain. Interestingly, even though Beclin1
BARA is common to both complexes, its membrane-interacting loops are critical for complex II, but
have only a minor role for complex I.
Introduction
Lipids form membranes that delimit cellular compartments, but they also can act as signalling mole-
cules that recruit proteins to membranes. The chemical and compositional diversity of lipids help to
establish the identity of intracellular compartments and the nature of subdomains within these com-
partments. For example, the endoplasmic reticulum (ER) contains low levels of cholesterol and high
levels of unsaturated glycerophospholipids, whereas the plasma membrane has an abundance of
cholesterol and saturated sphingolipids and glycerophospholipids (Bigay and Antonny, 2012). Dif-
ferences in lipid composition give membranes their physicochemical characteristics, which can con-
trol the activities of membrane-associated enzymes. The lipid phosphatidylinositol 3-phosphate (PI(3)
P) plays important roles in the regulation of various intracellular events including autophagy, endocy-
tosis, phagocytosis, and vacuolar protein sorting. In mammals, PI(3)P is generated mainly by the
Class III phosphatidylinositol 3-kinase VPS34/PIK3C3, which phosphorylates the 3-OH position of
phosphatidylinositol (PI). However, in cells, VPS34 is not found alone. Instead, it forms two principal
complexes, complexes I and II. Both complexes have core components VPS34, VPS15 and Beclin 1
(Vps30 in yeast) bound to a specific component, which is either ATG14L (Atg14 in yeast) in
complex I or UVRAG (Vps38 in yeast) in complex II. This single subunit difference between these two
complexes localizes them to different membrane compartments. Complex I is active on autophago-
somes (Matsunaga et al., 2009; Sun et al., 2008; Itakura et al., 2008) and some ER compartments
(Hamasaki et al., 2013; Nascimbeni et al., 2017; Axe et al., 2008), in response to starvation. In
contrast, complex II is mainly active in endocytic pathways by partially co-localizing in mammalian
cells with Rab5- and Rab7-positive endolysosomal compartments as well as with Rab9-positive
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compartments important for endosome to TGN sorting (Itakura et al., 2008). As the membranes of
these different compartments vary, we have undertaken to determine how lipid composition affects
the lipid kinase activity of VPS34 complexes.
The PI(3)P generated by complex I appears in puncta at ER-mitochondria contact sites, at ER-
plasma membrane contact sites and on ER sites known as omegasomes, which are recognized by PI
(3)P-specific binding proteins such as DFCP (Nascimbeni et al., 2017; Prinz et al., 2020;
Hamasaki et al., 2013; Axe et al., 2008). These findings indicate that complex I is recruited to spe-
cific sites on membranes for its activation. This recruitment involves an upstream complex, the ULK1
complex (Atg1 complex in yeast) (Russell et al., 2013). However, how complex I itself associates
with membranes and is activated on them is unclear. Complex II recruitment to early endosomes
and activation is aided by Rab5 (Christoforidis et al., 1999; Murray et al., 2002), although the
mechanism by which this occurs is poorly characterized. PI(3)P produced by complex II, in turn, leads
to recruitment of various PI(3)P binding proteins that function in endocytic pathways such as Hrs,
EEA1, and sorting nexins (Gaullier et al., 1999; Xu et al., 2001). We have previously shown that
yeast complex II has a Y-shaped structure, with the one arm bearing Vps34 and Vps15 acting as the
catalytic arm, while the other arm bearing Vps30 and Vps38 is the adaptor arm (Rostislavleva et al.,
2015). A similar structural organization has been observed for human complexes I and II
(Young et al., 2019; Baskaran et al., 2014; Ma et al., 2017). The aromatic finger motif in the BARA
domain of Vps30 is important for membrane binding and kinase activity of complex II, shedding light
on the importance of the adaptor arm for membrane binding and kinase activity. Many previous in
vitro studies of Class III PI3K have used pure PI (Fassy et al., 2017; Lu et al., 2014; Munson and
Ganley, 2016; Russell et al., 2013; Zhong et al., 2009; Kim et al., 2013) or a lipid mixture of only
PI and PS as the substrate (Brier et al., 2019). This approach underestimates the effects that mem-
brane complexity could have on VPS34 activity. For this reason, we have devised alternative VPS34
assays to measure the activities of Class III PI3Ks on membranes whose character we can control.
Protein binding to membranes is affected by three important physicochemical parameters: mem-
brane electrostatics, lipid packing, and membrane curvature (Bigay and Antonny, 2012). The nega-
tive charge of intracellular membranes arises mainly from phosphoinositides and phosphatidylserine
(PS). PS is known to enhance membrane-protein interactions by binding to basic residues of proteins
(Xu et al., 2013; Yeung et al., 2009; Yeung et al., 2006; Zhu et al., 1999), whereas protein affinity
for a phosphoinositide may depend on both the net charge (the number of phosphates on the inosi-
tol ring) or stereochemistry of the phosphoinositide.
Lipid packing is determined by the shape of polar lipid headgroups and by saturation of acyl
chains. Unsaturated acyl chains only loosely pack into membranes due to the kinks introduced by
unsaturated bond(s), whereas completely saturated acyl chains provide a more uniform geometry
and can therefore pack tightly to restrict membrane flexibility (Bigay and Antonny, 2012). Packing
also depends on global membrane properties, such as stretching/compression, membrane curva-
ture, or membrane stress (Johner et al., 2014; Marsh, 2007; McMahon and Boucrot, 2015;
Bigay and Antonny, 2012). Membrane flexibility is important for processes such as vesiculation,
endocytosis and phagocytosis (Calder et al., 1990; Degreif et al., 2019; Jackson, 2018;
Schroit and Gallily, 1979; Manni et al., 2018). Phospholipids usually have a saturated fatty acyl
chain at position sn1 of the glycerophospholipid, while the sn2 fatty acyl chain can be saturated,
monounsaturated or polyunsaturated. Phospholipids with two polyunsaturated fatty acyl chains
make membranes more flexible, but very permeable, while the more common sn1-saturated-sn2-
polyunsaturated enable flexibility with low membrane permeability (Manni et al., 2018). Acyl chain
saturation status also influences membrane curvature. Unsaturated lipids can tolerate high mem-
brane curvature, whereas the shapes of saturated lipids are cylindrical, making membranes contain-
ing them flatter. ER membranes are enriched with unsaturated phospholipids, enabling high
membrane curvature. This facilitates protein secretion from the ER. In contrast, PM membranes are
more tightly packed, due to the abundance of saturated phospholipid, which creates a thick bound-
ary between the cell and its environment (Holthuis and Menon, 2014; Bigay and Antonny, 2012).
Here, we have developed a purely in vitro system with purified VPS34 complexes I and II in which
we can directly control membrane bilayer properties, including acyl chain saturation of both sub-
strate and non-substrate lipids, membrane charge and membrane curvature. By combining HDX-MS
with mutagenesis and lipid kinase assays, we have investigated which domains and motifs of
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complex I and complex II are important for membrane binding and kinase activity, and which physi-
cochemical parameters of membranes have the greatest impact on complexes I and II.
Results
To assess how membrane properties modify the activities of VPS34 complexes, we have developed
a quantitative confocal microscopy assay to measure the activity of the human Class III PI3K com-
plexes on giant unilamellar vesicles (GUVs), which have a radius of ~ 1–30 mm. Purified, recombinant,
monodisperse VPS34 complexes I or II (Figure 1A) were incubated with Lissamine-Rhodamine
labelled GUVs containing PI and an AlexaFluor647-labelled PX domain, which specifically binds PI(3)
P (Ellson et al., 2001; Figure 1B). By following the rate of recruitment of the PX domain to the
GUVs, we can estimate the PI(3)P production and compare the relative activities of the complexes
on a range of membrane types.
Human complex I is more active than complex II
We first compared the activities of complexes I and II on membranes containing 18% PI (with a
mixed chain distribution, purified from bovine liver, hereafter called mixed chain PI), 10% DOPS,
17% DOPE, and 55% DOPC (see Supplementary files 1 and 2). This lipid headgroup composition
resembles the ER membrane and we will refer to it as the base lipid composition or ‘DO base’. On
DO base lipids, human complex I showed higher activity than complex II. Complex I showed a 7-fold
higher initial rate compared with complex II (Figure 1C). Next, we examined whether the difference
in activity between complexes I and II could be because complex II, which is normally active on early
endosomes, was not assayed on endosome-mimicking membranes. There is evidence that early
endosomes are rich in cholesterol and sphingomyelin (Bissig and Gruenberg, 2013;
Arumugam and Kaur, 2017; Kobayashi et al., 2002). Therefore, we measured the activity of com-
plexes I and II in the presence of 10% cholesterol and 10% sphingomyelin (Figure 1—figure supple-
ment 1). This showed that even with this membrane composition, complex I remained more active
than complex II. In order to compare the ability of complexes I and II to bind membranes, we carried
out a flotation assay (Figure 1D). This revealed that fractions 1–3, which contained
floating liposomes, included much more complex I when compared to the same fractions with
complex II (Figure 1D). The correlation of the activity assays with the membrane binding assay
strongly suggests that complex I is more active than complex II because complex I binds membranes
more tightly than complex II.
Both substrate and non-substrate lipid unsaturation as well as
membrane curvature greatly increase VPS34 activities
We examined how lipid packing affects VPS34 activities by varying the saturation status of the acyl
chains. For each complex, we compared VPS34 activity on GUVs composed of different percentages
of phospholipids with either stearoyl (18:0) or oleoyl (18:1) acyl chains (Figure 2A). As stearoyl acyl
chains are saturated, they cause a tighter lipid packing than the mono-unsaturated oleoyl chains.
Whereas SO lipids are made with one stearoyl and one oleoyl acyl chain, DO lipids carry two oleoyl
acyl chains. Three different lipid compositions were examined: 82% DO lipids (18:1-18:1), 82% SO
lipids (18:0-18:1), and 55% SO with 27% DO lipids (55% SO+27% DO) (Figure 2B). In each case, we
varied only the acyl chain saturation of the non-substrate lipids while we kept the source of the PI
and the relative proportions of PI, PS, PE and PC the same. GUV assays revealed that complexes I
and II were only active on 82% DO lipids and not on 55% SO+27% DO or 82% SO (Figure 2C and
D), suggesting that loose lipid packing activates complexes I and II. However, Z-stack analysis of ten
Z slices, which covers a range of vesicle sizes revealed some activity on smaller vesicles with 55% SO
+27% DO, but not on vesicles with 82% SO (Figure 2E and F). To examine this further, the curva-
tures (1/radius) for each GUV mixture were plotted against their fluorescence intensities. GUVs with
55% SO+27% DO displayed a positive correlation between increasing membrane curvature and
activity for both complexes I and II, but 82% SO GUVs did not exhibit this correlation (Figure 2G
and H). This suggests that high membrane curvature can at least partially compensate for the nega-
tive effect of lipid saturation.
We also examined the effect of lipid saturation of the substrate PI, while not changing the sur-
rounding non-substrate lipids made of DO (Figure 3A). Four PI species were examined: DSPI (18:0-
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Figure 1. Activities of human complexes I and II on GUVs. (A) SEC-MALS analysis of purified human Class III PI3K complex I (left panel) and complex II
(right panel). The protein samples were run on a Superose 6 10/300 column. Insets: SDS-PAGE of starting material stained with Coomassie staining.
Both complex I and complex II are monodisperse, with an average mass for complex I consistent with a 1:1:1:1 Beclin 1/VPS15/VPS34/ATG14L complex
(370 kDa, theoretical mass: 363 kDa) and an average mass for complex II consistent with a 1:1:1:1 Beclin 1/VPS15/VPS34/UVRAG complex (384 kDa,
theoretical mass: 386 kDa). (B) Assay design for activities of human complexes I and II on GUVs, using confocal microscopy and a labelled PI(3)P-
binding p40-PX domain (AF647-PX). Fluorescence from the Lissamine-Rhodamine (Liss-Rhod GUV) channel delineates the membrane, while the AF647
is indicative of VPS34 activity on the membrane. Scale bar: 5 mm. (C) Complex I is more active than complex II on GUVs with ‘DO base’ lipids (18%
Figure 1 continued on next page
Ohashi et al. eLife 2020;9:e58281. DOI: https://doi.org/10.7554/eLife.58281 4 of 28
Research article Biochemistry and Chemical Biology Structural Biology and Molecular Biophysics
18:0), SAPI (18:0-20:4), DOPI (18:1-18:1) and the mixed chain PI (Figure 3A). GUV assays with
complex I showed that DOPI was the best substrate, followed by the mixed chain PI and SAPI. How-
ever, with the more saturated acyl chains of DSPI, the activity of complex I was greatly reduced
(Figure 3B).
As a control, we tested whether lipid packing could affect binding of the AF647-PX reporter
domain to PI(3)P. We found that GUVs with 3% DOPI(3)P in 82% SO lipids showed a similar PX bind-
ing as the GUVs with 3% DOPI(3)P in 82% DO lipids (Figure 3C), indicating that membrane packing
had little effect on PX binding. The binding of the PX reporter to DSPI(3)P and SOPI(3)P containing
GUVs was not tested, since there is no commercial source of these lipids.
Together, these results show that lipid packing affects the complexes I and II activities, with both
complexes showing a dramatic preference for unsaturated lipids, in both the general background
lipids of the membrane and in the PI substrate for the enzyme. They also show that the negative
impact of tight lipid packing on activities of VPS34 complexes can be partially compensated by
increased membrane curvature.
Increasing negative membrane charge activates complex I, complex II,
and VPS34 alone
In order to examine the effect of negative membrane charge on VPS34 activity, we made mem-
branes with increasing proportions of the negatively charged lipid PS. We compared activities on
GUVs with 10% PS (DO base lipids) and 25% PS (DO high PS lipids) (Figure 4A and B). Using VPS34
alone, we could see no activity on GUVs with 10% PS. However, on GUVs with 25% PS, VPS34 activ-
ity was clearly detectable (Figure 4C). Also, complexes I and II showed substantial activation on 25%
PS compared with 10% PS GUVs (Figure 4D and E). As shown before, the activity of complex II on
10% PS (DO base lipids) was lower than that of complex I (Figures 1D and 4F). However, when the
two complexes were compared on 25% PS (DO high PS), complexes I and II had nearly the same
activity, suggesting a higher preference of complex II for negative charge (Figure 4G).
Membranes influence structures and dynamics of the VPS34 complexes
We used hydrogen-deuterium exchange mass-spectrometry (HDX-MS) to determine the regions in
the complexes I and II involved in membrane interaction. The advantage of HDX-MS is that it can
map direct interactions of the native, unlabelled protein with membranes as well as mapping confor-
mational changes associated with membrane binding (Masson et al., 2016).
The HDX-MS experiment for complex I had a sequence coverage of 87% (Supplementary file 4).
Several regions in complex I showed a reduction in solvent exchange in the presence of 100 nm
LUVs (Figure 5). The most pronounced HDX reduction was in a region of the BATS domain of
ATG14L (residues 478–492), with additional changes in Beclin 1 and VPS34. In Beclin 1, three regions
show protection in the presence of membranes, one in coiled-coil II (residues 201–212), another in
the CC2/BARA linker (residues 262–274) and the third in a region that has been referred to as the
BARA domain aromatic finger (AF1, residues 343–359 Huang et al., 2012). In the VPS34 kinase
Figure 1 continued
mixed chain PI, 10% DOPS, 17% DOPE and 55% DOPC). In the lower panels, the initial rates after a lag phase (AF647-PX fluorescence change/min in
arbitrary units, AU) and confocal images corresponding to the AF647-PX and Liss-Rhod channels at the end of the reaction are shown. For clarity, only
mean values of measurements for each time point in the reaction progress curves are plotted here and throughout all figures. Plots with SDs for each
time point are shown in Supplementary file 3. All scale bars: 5 mm. ***: p<0.001 (p<0.0001). Figure 1—figure supplement 2 illustrates some of the
raw images that were used for quantification. Scale bars: 15 mm. (D) Membrane binding of complexes I and II using a lipid flotation assay. Large
unilamellar vesicles (LUVs, 100 nm) and proteins were mixed and pipetted on a sucrose gradient. The gradient was then centrifuged, fractionated and
analysed by SDS-PAGE. Fractions 1–3 are the least dense fractions of a sucrose gradient, containing floating vesicles and membrane-bound proteins.
Fractions 5–6 are the highest density sucrose fractions, containing the pelleted proteins. The complexes alone sediment into the denser portion of the
gradients (left), but the presence of LUVs cause the complexes to associate with LUVs floating on the top of the gradient (right). Gel quantification can
be seen in Figure 1—figure supplement 3.
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Activities of complexes I and II on GUVs containing cholesterol and sphingomyelin.
Figure supplement 2. Selected images of GUVs for the time courses shown in Figure 1C.
Figure supplement 3. Quantification of membrane binding of complex I (A) and complex II (B) using a lipid flotation assay (Figure 1 (D)).
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Figure 2. Effect of non-substrate lipid packing on complexes I and II. (A) Structures of a phospholipid with DO (1,2-dioleoyl) acyl chains or SO (1-
stearoyl-2-oleoyl) acyl chains. (B) Lipid mixtures used to examine the effects of saturation of the non-substrate, ‘background’ lipids on activities of
complexes I and II. The 82% DO lipids means that all of the background lipids (PC, PS and PE) are 1,2-dioleoyl (DO) lipids. Similarly, 82% SO means all
of the background lipids are 1-stearoyl-2-oleoyl. (C) GUV assays for complex I using the lipid compositions shown in (B). Only the DO background lipids
Figure 2 continued on next page
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domain, helices k a1 and k a2 and the loop connecting them (residues 558–573) had a reduction in
HDX. When the protected areas were overlaid onto a model of human complex I, the AF1 of Beclin
1, and the k a1-k a2 of VPS34 delineate a putative membrane-binding surface (Figure 5B). Although
Figure 2 continued
(82% DO) show significant activity. (D) GUV assays for complex II as in (C). (E) and (F) Z-stack analysis of (C) and (D). At 60 min, ten Z slices were
obtained from an area, then projected into one plane with maximum projection to cover a wide range of sizes. Upper right cropped areas: Magnified
images of the boxed areas. Scale bars: 15 mm. (G) and (H) Correlation between fluorescence intensity and membrane curvature (1/GUV Radius) from the
same data as in (E) and (F), respectively. Right: Slopes for the plots. ***: p<0.001 (for (G) p<0.0001), (for (H) p<0.0001). For clarity, only mean values are
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Figure 3. Increasing substrate PI acyl chain unsaturation increases complex I activity. (A) Structures of the PI lipids used in the context of the DO base
background lipids. (B) Activities of complex I on GUVs containing the various PI substrates shown in (A) in the context of DO base background lipids.
***: p<0.001 (for all p<0.0001); *: p<0.05 (mixed chain PI vs SAPI p=0.0250). (C) Binding of the AlexaFlour 647-labelled p40 PX domain to 3% PI(3)P-
containing GUVs is not dependent on lipid saturation of the background lipids. n.s.: not significant (p=0.7645). For clarity, only mean values are plotted
for each time point. Plots with SDs for each time point are in Supplementary file 3.
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Figure 4. PS is an activator for complex I, complex II, and VPS34 alone. (A) Structures of DO phospholipid backbone (top) and head group for PE, PC,
and PS (bottom). (B) Lipid compositions used to examine the influence of additional PS on VPS34 activity. (C–E) Activities of VPS34 alone, complex I and
complex II on GUVs containing 10% PS (DO base) and 25% PS (DO high PS). Images were obtained 60 min after adding enzyme. (C) Activity of VPS34
alone (20 nM) on GUVs with 10% PS (DO base) and 25% PS (DO high PS). (D) Activity of complex I (20 nM) on GUVs with 10% PS (DO base) and 25% PS
(DO high PS). (E) Activity of complex II (100 nM) on GUVs with 10% PS (DO base) and 25% PS (DO high PS). (F) and (G) Comparison of complexes I and
II (20 nM) on GUVs with 10% PS (DO base) (F), or on 25% PS (DO high PS) (G). (F) ***: p<0.001 (p<0.0001); (G) n.s.: not significant (p=0.9274). For clarity,
only mean values are plotted for each time point. Plots with SDs for each time point are in Supplementary file 3. All scale bars: 5 mm.
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Figure 5. Analysis of membrane binding of human complex I using HDX-MS. (A) Representative peptides in complex I that showed significant HDX
changes in the presence of lipids. (B) Overview of HDX changes illustrated on a model of human complex I. The model was built using SWISSMODEL
and the structure of yeast complex II (PDB ID: 5DFZ). Peptides showing changes in HDX upon membrane binding are indicated by arrows. The model is
colored by differences in HDX between the absence and presence of membranes (right inset). The left inset shows a schematic of complex I, identifying
Figure 5 continued on next page
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there is no structure for the BATS domain, this region was shown to be involved in membrane bind-
ing (Fan et al., 2011).
We also performed HDX-MS for complex II in the presence and absence of 100 nm LUVs (Figure 6
and Supplementary file 5). We see prominent protection in the presence of membranes in Beclin 1
and VPS34. The Beclin 1 CC2/BARA linker had decreased HDX in the presence of membranes in
complex II similarly to complex I. Furthermore, as in complex I, the aromatic finger (AF1) of the
Beclin 1 BARA domain showed decreased HDX in complex II (residues 358–359). Surprisingly, two
additional regions, 288–300 and 409–419, were picked up in Beclin 1 at the putative membrane
interface. We will refer to 288–300 as the hydrophobic loop (HL) and 409–419 as the aromatic finger
2 (AF2). In VPS34 (in the context of complex II), a peptide (874-884) from the C-terminal helix of
VPS34 catalytic subunit showed protection. We had previously shown that the C-terminal helix is crit-
ical for catalysis on membranes (Miller et al., 2010). Although both complexes I and II show protec-
tion in the same domains, Beclin 1 BARA and VPS34 kinase, there are differences in the peptides
protected that suggest that the two complexes assume similar but distinct orientations on
membranes.
The ATG14L BATS domain is critical for the activity of complex I on
membranes
Although it has been shown that the BATS domain is important for membrane binding, it is not clear
how membrane properties affect this interaction and complex I activity (Brier et al., 2019;
Fan et al., 2011; Ma et al., 2017). Sequence analysis suggests that the BATS domain has an amphi-
pathic a-helix referred to as the amphipathic lipid packing sensor (ALPS) (residues 471–492), and
hydrophobic residues 484W, 485F, and 488Y within this motif are important for the binding of the
BATS domain to SUVs and for the localization of ATG14L to autophagosomes (Fan et al., 2011).
Using the GUV assay, we compared activities of complex I carrying a BATS mutation in which the
ALPS motif was truncated (DALPS 471–492) with the wild-type complex I (WT) (Figure 7A). On DO
base lipids (Figure 7B), the DALPS mutant showed no activity, suggesting that the motif is essential
for the complex I activity on membranes. Even on GUVs made with DO high PS, the DALPS mutant
of complex I showed hardly any detectable activity (Figure 7C). Surprisingly, complex I DALPS dis-
played significantly less activity than VPS34 alone on GUVs containing 25% PS (Figure 7C). This sug-
gests that the non-catalytic subunits of complex I partially inhibit basal VPS34 activity in the absence
of the ALPS motif. To determine whether the increase in activity conferred on complex I by the
BATS domain is an intrinsic property of the domain, we fused the BATS domain to the C-terminus of
the full-length UVRAG subunit and co-expressed it with other complex II subunits (Figure 7A). This
fusion complex was shown previously to increase membrane binding of complex II (Ma et al., 2017).
We found that the fusion complex II (UVRAG+BATS) showed increased activity, about 7-fold com-
pared with the wild-type complex II (CII WT, Figure 7D). The human UVRAG has a 235 amino-acid
long C-terminal extension compared to its yeast orthologue Vps38. When this UVRAG-specific
extension was deleted and the BATS domain was fused to the truncated UVRAG, the resulting
complex II variant (UVRAG DC+BATS, Figure 7A) showed an even higher activation of 11-fold over
the WT complex II (Figure 7D). This suggests that the presence or absence of the UVRAG C-terminal
region alters the orientation of the BATS domain with respect to the membrane. Interestingly, both
UVRAG+BATS and UVRAG DC+BATS exhibited even higher activity than complex I WT (Figure 7D).
Our activity results are consistent with the previous studies showing that the presence of the BATS
domain increased membrane binding (Ma et al., 2017). Together with our HDX-MS results, this
strongly indicates that the BATS domain activates complex I through a mechanism that involves an
increase in membrane binding, and that the BATS domain can act as an autonomous membrane-
interacting module that confers gain of function to VPS34 activity.
Figure 5 continued
the subunits. CC1: coiled-coil I; CC2: coiled-coil II; CC3: coiled-coil III; BARA: b-a-repeated, autophagy-specific domain; C2: C2 domain; Helical: helical
domain; Kinase: kinase domain; WD40: WD40 domain; BATS: BATS domain; C-term: ATG14L C-terminal domain.
Ohashi et al. eLife 2020;9:e58281. DOI: https://doi.org/10.7554/eLife.58281 10 of 28












































Beclin 1, BARA domain
peptide 340-359

























Beclin 1, BARA domain
peptide 413-419






























































Figure 6. Analysis of membrane binding of human complex II using HDX-MS. (A) Representative peptides in complex II that showed significant HDX
changes in the presence of lipids. (B) Overview of HDX changes illustrated on a model of human complex II. The model was built using SWISSMODEL
and the structure of yeast complex II (PDB ID: 5DFZ). Peptides showing changes in HDX upon membrane binding are indicated by arrows. The model is
colored by differences in HDX between the absence and presence of membranes (right inset). The left inset shows a schematic of complex II identifying
Figure 6 continued on next page
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Figure 6 continued
the subunits and domains. CC1: coiled-coil I; CC2: coiled-coil II; BARA: b-a-repeated, autophagy-specific domain; BARA2: BARA2 domain; C2: C2
domain; Helical: helical domain; Kinase: kinase domain; WD40: WD40 domain; C-term: UVRAG C-terminal extension.
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Figure 7. Influence of the Amphipathic Lipid Packing Sensor (ALPS) motif in the ATG14L BATS domain on the activities of complexes I and II. (A)
Constructs used to examine the influence of the BATS domain on VPS34 activity in the contexts of complex I and a complex I/II chimera on GUVs. (B)
The ALPS motif of the BATS domain is important for the activity of complex I. Upper: Activities of wild-type complex I (WT), and complex I with the
DALPS mutations on GUVs with DO base lipids. Lower left: Initial rates. Lower right: Confocal micrographs of the GUV assay at 60 min after adding
proteins. ***: p<0.001 (p<0.0001). (C) Activities of WT and DALPS complex I as well as the VPS34 kinase subunit on its own on GUVs with DO high PS.
***: p<0.001 (for all p<0.0001). (D) Activities on GUVs with DO base lipids for complex II and for fusions of the BATS domain to UVRAG C-terminus. U +
BATS: UVRAG + BATS; UDC + BATS: UVRAGDC + BATS as illustrated in (A). ***: p<0.001 (for all p<0.0001); **: p<0.01 (CI WT vs CII U+BATS p=0.0059).
For clarity, only mean values are plotted for each time point. Plots with SDs for each time point are in Supplementary file 3. All scale bars: 5 mm.
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The Beclin 1 BARA domain is more important for the activity of
complex II than complex I
Three motifs, aromatic finger 1 (AF1, 359-FFW-361), aromatic finger 2 (AF2, 418-QF-419), and the
hydrophobic loop motif (HL, 293-LPSVPV-298) found in the BARA domain of Beclin 1 are part of the
putative membrane interface (Figure 8A). HDX-MS showed that membrane binding decreased HDX
for only AF1 in complex I, whereas HL, AF1 and AF2 had reduced HDX in complex II (Figure 8A).
This suggests that the BARA domain might bind membranes differently in the context of complex I
and complex II (Figure 8A, middle panel). We measured the activities of both complexes I and II
when carrying mutations in these motifs (AFM1 = F359D F360D W360D, AFM2 = Q418D F419D,
and HLM = L293D V296D) in order to examine their importance. This revealed that complex I carry-
ing AFM1 or AFM1+HLM (both AFM1 and HLM) had reduced but still significant activities
(Figure 8B), while AFM2 did not affect the complex I activity (Figure 8C). In contrast, complex II
activity depended on all three motifs (Figure 8D). This suggests that complex I activity is more
dependent on the BATS domain than the BARA domain, with HL and AF2 dispensable for
complex I. On the other hand, complex II activity is critically dependent on the BARA domain, where
AF1, AF2 and HL are all essential for full activity.
Phosphoinositides have modest effects on activities of complexes I and
II
Phosphoinositides (PIPs) represent about 10% of total phospholipids, and less than 1% of total lipids
in biological membranes (De Craene et al., 2017; Payrastre et al., 2001). However, specific PIPs
are enriched in distinct organelle membranes, and this helps to selectively recruit proteins. Since
previous work established the importance of kinases that generate phosphatidylinositol 4-phosphate
(PI(4)P) and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) in autophagy (Wang et al., 2015;
Tan et al., 2016), we examined the influence of PI(4)P and PI(4,5)P2 on complexes I and II. For this,
we added either 5% DOPI(4)P or 5% DOPI(4,5)P2 in place of 5% DOPC to the DO base lipids
(Figure 9A, B and C). We found that complex I was activated by PI(4)P (~1.8 fold) and by PI(4,5)P2
(~1.2 fold) compared to DO base lipids (Figure 9D and E). In contrast, complex II was also modestly
activated by PI(4)P (~1.7 fold) (Figure 9F) but unaffected by PI(4,5)P2 (Figure 9G). The activation of
complex I by PI(4,5)P2 is consistent with the observation that the isolated BATS domain of ATG14L
has a binding preference for PI(4,5)P2, in addition to its ability to sense membrane curvature
(Fan et al., 2011; Tan et al., 2016).
Discussion
In this study, we systematically examined the importance of three physicochemical membrane
parameters on the lipid kinase activities, structures and dynamics of VPS34 complexes I and II. We
found that all three parameters, packing defects caused by acyl chain unsaturation for both substrate
and non-substrate lipids, membrane curvature and electrostatics, significantly affected the activity of
both complexes. It was surprising that changing the saturation status on just one of the two acyl
chains dramatically altered the activity of both complexes. Variations in acyl chain composition of
glycerophospholipids can give rise to thousands of lipid species. Nevertheless, mammalian cells
have some distinct patterns of acyl chain enrichments. One notable example of this is that 40–85%
of PI is present as SAPI (18:0/20:4) (Barneda et al., 2019; Blunsom and Cockcroft, 2020;
Bozelli and Epand, 2019). We showed that VPS34 kinase is activated by unsaturation of its substrate
PI (Figure 3B). This is consistent with the observation in C. elegans that depletion of an enzyme that
incorporates polyunsaturated fatty acids (PUFAs) in the sn-2 position of PI significantly decreased PI
(3)P content and size of early endosomes, without reducing total PI (Lee et al., 2008; Lee et al.,
2012). More surprising was our result that increasing unsaturation of the background lipids also dra-
matically increased activities of complexes I and II (Figure 2). The effect of background lipids unsatu-
ration is likely to be mediated largely by the adaptor arm, since VPS34 alone shows no activity on
DO base (10% PS) lipids (Figure 4C), whereas complexes I and II on the same lipid mixture are active
(Figure 4D and E). Stearoyl-CoA desaturase activity is important for early steps in autophagy
(Ogasawara et al., 2014; Köhler et al., 2009), and recent lipidomic analyses have shown that auto-
phagic membranes of budding yeast contain as much as 60% lipids with two unsaturated fatty acyl
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Figure 8. Influence of Beclin 1 BARA domain mutations on the activities of complexes I and II. (A) Summary of HDX changes for the Beclin 1 BARA
domain of human complex I (left) and II (right) overlaid on a ribbon diagram of the structure of the domain (PDB ID 4DDP). In the middle panel,
peptides are coloured by whether they are specifically protected in complex I (orange), complex II (green), or both complexes I and II (blue). Elements
involved in HDX changes are AF1 (Aromatic finger motif 1; 359-FFW-361), AF2 (Aromatic finger motif 2; 418-QF-419), and HL (Hydrophobic loop; 293-
Figure 8 continued on next page
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moieties, and only 2% with no double bonds (Schütter et al., 2020). The potent effect of lipid unsa-
turation on VPS34 complexes combined with the compartment-specific lipid unsaturation suggests
an important means of modulating VPS34 activity on cellular organelles. The importance of lipid
unsaturation for VPS34 activity is analogous to what was reported for another lipid kinase involved in
the generating polyphosphoinositides. Increasing acyl chain unsaturation for substrate and non-sub-
strate lipids in detergent micelles activates phosphatidylinositol-4-phosphate 5-kinase isoforms
(Shulga et al., 2012).
The human VPS34 complexes were activated by increased membrane curvature (Figure 2), which
is consistent with results for the yeast complexes I and II (Rostislavleva et al., 2015) and human
complexes I and II (Brier et al., 2019). An alternative possibility that cannot be excluded is that
smaller GUVs incorporate more unsaturated lipid during their formation and hence are able to
recruit the two complexes more efficiently. Membrane curvature causes tilting of lipids and
decreased lipid packing, thereby opening hydrophobic cavities that can be sensed by protein motifs
like the ALPS motif from complex I (Vanni et al., 2014) and motifs from the BARA domain of both
complexes I and II. Although the VPS34 complexes make protein/protein interactions that help local-
ize them to specific lipid compartments, the preference for high curvature and lipid unsaturation
may contribute to the lack of activity of these PI3K complexes at the PM, which is enriched with satu-
rated lipids and has a lower curvature (Bigay and Antonny, 2012). Rab5 is a primary determinant
for recruiting complex II to early endosomes. Interestingly, like complex II, Rab5 has a preference for
target membranes with high curvature and monounsaturated lipids, and this preference derives from
the unsaturated prenyl lipids attached to Rab5 fitting into packing defects in the target membrane
(Kulakowski et al., 2018). Curvature and lipid packing are closely linked, consequently, the loss of
VPS34 activity caused by tight lipid packing of saturated lipids can be counteracted by an increase in
membrane curvature (Figure 2).
As the third physicochemical parameter, we tested the effects of electrostatics on the activities of
VPS34 complexes by increasing the concentration of phosphatidylserine (PS). PS is enriched on the
cytosolic leaflet of the plasma membrane (PM) and endocytic vesicles mainly at recycling endosomes
(RE) (Fairn et al., 2011). The PS on the cytosolic leaflet plays important roles in the regulation of
endocytic pathways (Uchida et al., 2011). We found that PS activates complexes I and II, and also
VPS34 alone (Figure 4C–E). Significantly, GUVs with 25% PS enabled complex II to achieve the same
activity as complex I (Figure 4G), whereas on membranes with 10% PS, complex I was much more
active than complex II (Figure 4F). The ability of high PS content to strongly activate complex II
might contribute to complex II activity on early endosomes, which have more PS than the ER (Hullin-
Matsuda et al., 2014). It is reasonable to hypothesize that PS, together with Rab5, may contribute
to activation of complex II on early endosomes. Increased PS in combination with high curvature and
loosely packed lipids may contribute also to activation of complex I during autophagy. In cells, PS is
synthesized by PS synthases (PSS) I and II at the ER-mitochondria-associated membranes (MAM)
(Lagace and Ridgway, 2013). Upon starvation, complex I is recruited to the MAM (Hamasaki et al.,
2013). The PSS I co-localizes with FIP200, a member of autophagy-initiation complex, which is nec-
essary for the recruitment of complex I (Nishimura et al., 2017). ER membranes are enriched in
loosely packed lipids, and the site of initiation of the phagophore is a highly curved structure known
as an omegasome (Axe et al., 2008). This would provide an ideal platform to activate complex I.
However, membrane properties alone would not explain the proclivity of complex I to provide PI3K
activity in autophagy compared with complex II. Additional interactions could contribute to enrich-
ment of complex I on autophagosomes. Recently, it was shown that the ATG14L BATS domain may
be acting as a coincidence detector, using its ALPS motif to interact with membranes and its LIR
Figure 8 continued
LPSVPV-298). (B–D) Effects of mutations in the membrane-binding elements of complexes I and II on activities using GUVs with DO base lipids. Top:
Reaction progress curves. Only mean values are plotted. Plots with SDs are in Supplementary file 3. Bottom: initial rates. (B) AFM1 and HL mutations
in the BARA domain modestly affect the activity of complex I on GUVs. Beclin 1 constructs: wild-type (WT), aromatic finger one mutant (AFM1), and
AFM1+ hydrophobic loop mutant (AFM1+HLM). ***: p<0.001 (p<0.0001); n.s.: not significant (p=0.4238). (C) AFM2 mutation has no influence on
complex I activity. n.s.: not significant (p=0.5186). (D) All of the mutations have an effect on complex II activity. ***: p<0.001 (for all p<0.0001). For clarity,
only mean values are plotted for each time point. Plots with SDs for each time point are in Supplementary file 3. ***: p<0.001; n.s.: not significant.
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Figure 9. Effects of phosphoinositides on complexes I and II. Activities of GUVs in which 5% of the PC in the base mixture is replaced by either 5% PI(4)
P or 5% PI(4,5)P2 compared with base lipid-containing GUVs. (A) Composition of GUVs. (B) General structure of a phosphatidylinositol headgroup. (C)
Structures of DOPI(4)P and DOPI(4,5)P2. (D-G) For each figure, the upper panel shows the reaction time course, the lower left panel shows the initial
rates and the lower right illustrates confocal micrographs 60 min after adding the enzyme complexes. (D) Influence of 5% DOPI(4)P on complex I
activity. **: p<0.01 (p=0.0059). (E) Influence of 5% DOPI(4,5)P2 on complex I activity. *: p<0.05 p=0.0140). (F) Influence of 5% DOPI(4)P on complex II
Figure 9 continued on next page
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motif to interact with autophagic GAPARAPs (Birgisdottir et al., 2019). Along with the ULK1 com-
plex, they may contribute to autophagosome-specific localization and activation.
Both the HDX-MS results and the mutational analyses suggest that complexes I and II have some
complex-specific as well as common interactions with membranes. On GUVs made with DO base lip-
ids, human complex I is considerably more active than complex II, which stands in contrast to our
results for yeast VPS34 complexes, where complex II was more active than complex I
(Rostislavleva et al., 2015). The contrasting behaviour of human and yeast VPS34 complexes likely
arises from extensive sequence differences between human and yeast Atg14, particularly in the
region corresponding to the C-terminal BATS of ATG14L. The complex I BATS domain interaction
with membranes is the most striking of the complex-specific membrane interactions in the human
VPS34 complexes. The BATS dominates the complex I membrane interaction. When the BATS
domain is deleted, almost all of complex I activity is eliminated (Figure 7). Furthermore, complex I
binds to membranes more strongly than complex II (Figure 1D and Ma et al., 2017). Adding the
BATS domain to either full-length UVRAG or a UVRAG fragment lacking the C-terminus dramatically
increased complex II activity (Figure 7D) and membrane binding in vitro and in cells (Ma et al.,
2017). Our results suggest that the differences in activities for complexes I and II reflect a lower
affinity of complex II for lipid vesicles (Figure 1C and D). In cells, this weak membrane affinity of
complex II may be compensated by its binding partners, such as Rab5, which help to recruit
complex II to membranes (Christoforidis et al., 1999). Our results also show that the activities of
complexes I and II become equalized on lipid vesicles with increased PS, and this is consistent with a
previous report that complexes I and II have identical activities on LUVs formed with 50%PS and
50%PI (Brier et al., 2019).
To our surprise, the ALPS deletion mutant showed even lower activity than VPS34 alone
(Figure 7C), suggesting that the influence of the ATG14L subunit is intrinsically inhibitory, but that
this inhibition is overcome by the much stronger membrane binding conferred by the BATS domain,
resulting in an overall gain of function. A similar mechanism has been reported for the H-Ras-PI3Ka
complex, where H-Ras binding is inhibitory for PI3Ka, but the inhibition is overcome by increased
recruitment of PI3Ka to membranes (Buckles et al., 2017). The presence of the ATG14L subunit
alters the interactions of the rest of the complex with membranes. This subunit appears to enhance
the association of the VPS34 kinase domain with membranes (giving rise to protection of the ka1-
ka2 region of VPS34; Figure 5). It also alters the interaction of Beclin 1 with membranes, so that
while the BARA domain AF1 motif has a role in membrane binding for both complexes, AF2 and HL
motifs are important only for complex II (Figures 5, 6 and 8). However, in the context of the domi-
nant role of the BATS domain on complex I activity, the influence of the Beclin 1 AF1 on activity is
minor, and there is no significant influence of AF2 or HL (Figure 8). This is consistent with the previ-
ous report that mutation of AF1 only mildly affects the autophagosome generation (Huang et al.,
2012). It may be that the BATS domain affects the orientation of complex I, so that AF2 and HL no
longer interact with membranes. In contrast to complex I, complex II depends critically on AF1, AF2
and HL to enable its maximal activity on membranes (Figure 8). The yeast complex II activity also
depends on AF1 (Rostislavleva et al., 2015), indicating that the activation mechanisms of these two
orthologous complexes are similar. The HL motif in the BARA domain (Figures 6 and 8) has S295
that can be phosphorylated by Akt (Wang et al., 2012), which enhances interactions of Beclin 1 with
14-3-3 and vimentin intermediate filament proteins. On the other hand, the S295A mutation enhan-
ces autophagy (Wang et al., 2012). In cells, the S295 phosphorylation by Akt and/or interaction with
14-3-3 may negatively affect membrane binding of complexes I and II.
In addition to the AF1 motif in the Beclin 1 BARA domain, another region showing decreased
HDX in both complexes I and II is the CC2/BARA linker of Beclin 1 (residues 262–274 in complex I
and residues 262–270 in complex II). It was proposed that hydrophobic residues Phe270 and Phe274
in this linker interact with lipid membranes (Chang et al., 2019). Consistent with this, mutation of
Phe270 and Phe274 eliminated membrane binding and activity of complex II (Chang et al., 2019).
The somewhat distant position of these two residues from the putative membrane-binding surface
Figure 9 continued
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plotted for each time point. Plots with SDs for each time point are in Supplementary file 3. All scale bars: 5 mm.
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marked by AF1, prompted the proposal that the adjacent BARA b1 and b2 strands become
unlatched to allow Phe270/Phe274 to reach the membrane. Although these two hydrophobic resi-
dues were protected from HDX in the presence of lipid membranes in our studies (Figures 5 and
6), the peptides covering the b1-b2 of the BARA domain b-sheet 1 (residues 275–287, 276–294,
Supplementary files 4 and 5) did not show significant HDX changes. In addition, in yeast, mem-
branes cause this region to increase in HDX (residues 312–327 in Vps30) (Rostislavleva et al., 2015).
Consequently, the question whether the CC2/BARA linker becomes more protected due to direct
interaction with membranes or due to an indirect ordering in the presence of membranes remains
an open question.
Both complexes I and II are activated by PI(4)P, This phosphoinositide is enriched on the Golgi
apparatus (Hammond and Balla, 2015), early endosomes (Henmi et al., 2016), and autophago-
somes (Judith et al., 2019; Wang et al., 2015), where complexes I and II are activated. The coinci-
dence of Rab5, PS, and PI(4)P at early endosomes might help to specifically enhance complex II
activity on this compartment. (Judith et al., 2019; Munson et al., 2015; Sridhar et al., 2013;
Wang et al., 2015) We also found that PI(4,5)P2 modestly increases activity of complex I
(Figure 9E). This could be mediated by binding of PI(4,5)P2 to the ATG14L BATS domain
(Wang et al., 2015; Tan et al., 2016). Interestingly, it was recently shown that PIPKIg i5, which phos-
phorylates PI(4)P to produce PI(4,5)P2, binds to ATG14L and localizes to autophagosomes
(Tan et al., 2016). Compared with the effects of the three membrane physicochemical parameters,
phosphoinositides PI(4)P and PI(4,5)P2 have only modest effects in vitro.
Overall, our results uncovered the importance of lipid packing dictated by acyl chain unsaturation
of both substrate and background lipids, negative charge, and membrane curvature for the activa-
tion of both complexes I and II. However, these complexes have unique cellular localization and
HDX-MS analysis revealed differences in membrane binding modes between complexes I and II that
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LUV generation
The LUV mixtures were mixed according to Supplementary file 1 in a glass vial. The mixture was
dried under a nitrogen gas, while rotating the tube so that a lipid film was formed on the vessel wall.
The remaining solvent was evaporated by placing the glass vial in a desiccator for 60 min. The lipids
were dissolved in lipid buffer (50 mM HEPES pH 8.0, 150 mM NaCl) and vortexed for 2 min. The
solution was transferred to a 1.5 mL Eppendorf Tube and sonicated for 2 min in a bath sonicator, fol-
lowed by 10 cycles of freeze/thaw in liquid nitrogen and a 43˚C water bath. The lipid mixture was
extruded 20 times through a 100 nm filter (Whatman Anotop 10 syringe filter 0.1 mm diameter, 10
mm Cat No 6809–1112). The lipid solution was then either used fresh or snap frozen in liquid
nitrogen.
GUV generation
An aliquot of 15 mL of a 1 mg/mL GUV lipid mixture in solvent was pipetted onto the Indium-Tin-
Oxide (ITO)-coated side of an ITO slide (Nanion) then dried in a desiccator for 1 hr. GUVs were
made in the presence of 220 mL of swelling solution (0.5 M glucose or sucrose), using a GUV maker
(Vesicle Pro, Nanion) programmed for 10 Hz; 60˚C; 1 Amp; 3 min rise; 68 min fall. After GUVs were
generated, they were immediately removed from the ITO slide and transferred to a 1.5 mL tube,
which had been incubated with 5 mg/mL BSA (Sigma A7030) for 1 hr then rinsed once with swelling
solution.
GUV immobilization
Wells of an eight well glass bottom chamber (Ibidi 80827) were treated with 100 mL of avidin solution
(0.1 mg/mL avidin egg white, Life Technologies A2667 dissolved in PBS, and 1 mg/mL BSA) for 15
min then washed two times with observation buffer (25 mM HEPES pH 8.0 and 271.4 mM NaCl). An
aliquot of 64 mL of observation buffer was added to the wells, followed by 48 mL GUVs then 20 mL of
0.1 mg/mL BSA-biotin (Scientific Laboratory Supplies A8549, dissolved in observation buffer). GUV
immobilization was checked on the microscope, then 20 mL of 10x buffer (250 mM HEPES pH 8.0, 10
mM EGTA, 20 mM MnCl2, 10 mM TCEP, and 1 mM ATP pH8.0) was added.
Microscopy
GUVs were observed with a 63x oil immersion objective (Plan-Apochromat 63x/1.40 Oil DIC, Zeiss)
on an inverted confocal microscope (Zeiss 780), using ZEN software (Zeiss). The observation cham-
ber was immobilized on a microscope stage holder using an adhesive (Blu-Tack, Bostik). In the ZEN
software, Time Series and Positions were selected. The Lissamine-rhodamine channel for GUVs was
exited with a Diode-pumped solid-state (DPSS) 561 nm laser and collected with a 566–629 nm band.
The Alexa Fluor 647 channel for the PX domain was exited using a HeNe 633 nm laser and collected
with a 638–756 nm band. Five to six areas per well were randomly selected so that at least 15 GUVs
could be analyzed. After areas were selected, an aliquot of 48 mL of a solution containing the kinase
complex and the PX domain in protein dilution buffer (25 mM HEPES pH8.0, 150 mM NaCl, 1 mM
TCEP, and 0.5 mg/mL BSA) was added to each well. The final concentrations of complex I,
complex II or VPS34 alone are described in figures and their legends. The PX domain was used at
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the final concentration of 7 mM. Images were obtained every 2–3 min for 60–120 min. For the Z-stack
analysis, the Z-Stack option was ticked in the Zen software. For the Z-Stack, slices were kept, and
the first and last positions were manually set and 10 slices were acquired.
Image analysis
Images were opened with Fiji software using Bio-Formats importer plugin. For the time course analy-
sis, partial or whole circles from GUV sections were selected using the ROI (region of interest) selec-
tion tool, and added to ROI manager. Fluorescence intensities were analyzed using a macro
(GUV_intensity.ijm. See ‘Confocal microscopy macro’ section below). A baseline signal of the AF647
channel originating from unbound PX domain and small membrane particles or vesicles, was sub-
tracted from all frames. To estimate this baseline, 10 regions without GUVs were selected and their
intensity profile over time was obtained with the ImageJ command ‘Plot Z-axis Profile’. These 10
profiles were averaged together to obtain a single temporal baseline that was later subtracted from
intensity measurement at the corresponding time points. Because this baseline signal appears earlier
than the actual enzyme activity, negative values are typically generated in the lag phase just before
the initial rate is achieved. In the case of the kinases with very weak or no activities (e.g., for the
BATS domain mutant and for VPS34 alone), the signal from the baseline is stronger than the signal
accumulated on the GUVs, thereby resulting in negative values after baseline subtraction. The initial
rate was calculated by carrying out linear regression with Prism7 (GraphPad Software) using the
points in the region of the AF647-PX signal reaction progress curve that showed a linear increase.
This region was located manually and typically started after a lag phase and before the plateau of
the AF647-PX signal. For the radius versus fluorescence intensity analysis (Figure 2), whole GUV cir-
cular sections were selected using Oval selection tool and added to ROI manager, and analyzed
using a macro (GUV_intensity1dimension.ijm). Ten random areas for baseline subtraction were
selected using the ROI selection tool, and the mean values were subtracted from the actual fluores-
cence intensities. Results were further analyzed using Microsoft Excel (Microsoft) and GraphPad
Prism7 (GraphPad Software).
Cell culture and transfection
Expi293 suspension cells (ThermoFisher A14527) were grown at 37˚C, 8% CO2, and 125 rpm shaking
in Expi293 Expression Medium (ThermoFisher A1435102). Cells at a density of around 2.0  106
mL 1 were transfected with plasmids at 1.1 mg/L culture, using 3 mg/L of polyethylenimine (PEI)
‘MAX’ (Polysciences 24765, 1 mg/mL in PBS). Cells were grown at 37˚C, 8% CO2, and 125 rpm shak-
ing for 48 hr, then harvested at 3000 g for 20 min, flash frozen in liquid nitrogen, and stored at  80˚
C, until they were used.
Flotation assay
An aliquot of 20 mL of sample was prepared containing: 1.8 mM or 1.5 mg/mL LUVs, 2 mM VPS34
complex in buffer containing 25 mM HEPES pH 8.0, 150 mM NaCl, 1 mM TCEP. The LUVs and pro-
teins were incubated on ice for 30 min. In the meantime, a sucrose gradient was prepared. Several
sucrose solutions were layered from bottom to top in a Beckman centrifuge tube (343775 Thickwall
Polycarbonate Tube): 40 mL 30% sucrose solution, 52 mL 25% sucrose solution, 52 mL 20% sucrose
solution. Then 16 uL of the LUV/protein sample was carefully pipetted on top of the gradient without
disturbing the layers. 2.5 mL of the remaining LUV/protein was kept as an input sample. The gradient
was then centrifuged for 3 hr in a TLS-55 rotor (Beckman Coulter) at 55,000 rpm and 4˚C. After-
wards, 6 fractions of 26 mL were carefully collected from the top of the gradient. The input and gra-
dient fractions were then loaded on an SDS-PAGE gel.
Protein purification
A protein purification method for human complex I was described previously (Ohashi et al., 2016).
Human complex II was purified in the same way as the complex I, except that the NaCl concentration
is at 300 mM throughout the procedures. All complex I and complex II mutants were purified in the
same conditions as the wild-type complexes. For the purification of human VPS34 alone, a plasmid
(pSM41) was transformed into E. coli C41(DE3) RIPL cells. The transformed bacteria were cultured in
2xTY medium containing 0.1 mg/mL ampicillin at 37˚C to an OD 600 of 0.8–1.0 and induced with 0.3
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mM IPTG at 12˚C for 15.5 hr. For a 4 L scale purification, cell pellets were resuspended in 100 mL of
sonication buffer (10 mM Tris-HCl pH 8.0, 100 mM NaCl, 10 mM imidazole, 1 Complete EDTA-free
Protease Inhibitor Cocktail Tablet (Roche, 11873580001), 0.1 mg/mL DNaseI, and 50 mL BugBuster
(Novogen 70584) and sonicated on ice for 3 min, which was repeated three times in total. Lysates
were subjected to ultracentrifugation at 100,000 g for 40 min at 4˚C. The supernatant was filtered
through a 0.45 mm filter (Millipore, SE2M230I04), before being passed through two connected 5 mL
Ni-NTA FF columns (GE Healthcare 17-5255-01). The bound protein was washed with 100 mL Ni A1
buffer (20 mM Tris pH 8.0, 300 mM NaCl, 10 mM imidazole, 2 mM b-mercaptoethanol), 100 mL Ni
A2 buffer (20 mM Tris pH 8.0, 100 mM NaCl, 10 mM imidazole, 2 mM b-mercaptoethanol), and
eluted with an imidazole gradient with about 80 mL of Ni B1 buffer (20 mM Tris pH 8.0, 100 mM
NaCl, 300 mM imidazole, 2 mM b-mercaptoethanol). The N-terminal His6 tag was cleaved with TEV
protease (made in house) and incubated overnight with gentle rocking at 4˚C. On the next day, the
protein was further purified on a 5 mL Heparin HP column (GE Healthcare 17040701) by first washing
with 20 mL HA buffer (20 mM Tris pH 8.0, 100 mM NaCl, 2 mM DTT) and then eluting with 100 mL
HB buffer (20 mM Tris pH 8.0, 2 mM DTT, 1 M NaCl). The heparin peak fractions were pooled and
brought to 100 mM NaNO3 to prevent precipitation during concentration in a 30,000 MWCO Ami-
con Ultra15 concentrator (Millipore UFC903024). The final purification step was carried out on a
Superdex 200 16/60 gel filtration column (GE Healthcare, 17-1069-01) that was pre-equilibrated with
running buffer (20 mM Tris HCl pH 8.0, 100 mM NaCl, 2 mM DTT). The peak fractions were pooled
and concentrated to 5.2 mg/mL (51 mM). For the purification of human phox 40 (construct GST-TEV
cleavage site-Cys-PX), a plasmid (pYO1125) was transformed into E. coli C41(DE3) RIPL cells. The
transformed bacteria were cultured in 2xTY medium containing 0.1 mg/mL ampicillin at 37˚C to an
OD 600 of 0.6 and induced with 0.3 mM IPTG at 30˚C for 16 hr. 6 L of cells were pelleted by 20 min
centrifugation at 4,000 g and the pellets were resuspended in 150 mL lysis buffer (20 mM HEPES pH
8.0, 200 mM NaCl, 1 mM TCEP, 0.05 mL/mL universal nuclease (ThermoFisher, 88702), 0.5 mg/mL
lysozyme (MP Biomedicals, 195303)). The cells were sonicated 6 min on ice (10 s on/10 s off, 60%
amplitude), and the lysates were spun at 30,000 g for 45 min at 4˚C. The supernatant was filtered
through a 0.45 mm filter (Millipore, SE2M230I04), and an aliquot of 2.5 mL of washed Glutathione
Sepharose beads was added (Glutathione Sepharose 4B, GE Healthcare 17-0756-05). The lysate was
incubated on the beads for 45 min with gentle rolling at 6 rpm at 4˚C. The beads were then trans-
ferred to a gravity flow column (Bio-Rad, 731–1550) and washed with 100 mL lysis buffer, 100 mL
wash buffer (20 mM HEPES pH 8.0, 300 mM NaCl, 1 mM TCEP) and 100 mL TEV buffer (20 mM
HEPES pH 8.0, 200 mM NaCl, 1 mM TCEP). The N-terminal GST tag was cleaved with TEV protease
and incubated overnight with gentle rocking at 4˚C. Next day, elution fractions were collected and
concentrated in a 10,000 MWCO Amicon Ultra15 concentrator (Millipore, UFC901024). The concen-
trated protein was loaded onto a Superdex 75 16/60 gel filtration column (GE Healthcare 17-1068-
01) and gel filtration was carried out in a buffer containing 20 mM HEPES pH 8.0, 200 mM KCl, 1
mM TCEP. The peak fractions were pooled and concentrated to 23.5 mg/mL (1.35 mM).
Labelling of the PX domain
For the labeling of the PX, 1 mg of AF647 C2 Maleimide kit (Life Technologies, A20347) was dis-
solved in 100 mL DMSO (ThermoFischer, Catalog No. BP231-100) to final 7.7 mM. For the final label-
ing reaction 250 mM PX, 2.5 mM TCEP, 385 mM AF647 dye was mixed with labeling buffer (50 mM
HEPES pH 7.0, 200 mM KCl) to a total volume of 1 mL, and the reaction was left for 2 hr at room
temperature on a roller at 10 rpm. After the incubation, 1 mM of DTT was added and the protein
was loaded on a 5 mL Heparin HP column (GE Healthcare 17040701). The column was first washed
with HA buffer (50 mM HEPES PH 8.0, 100 mM KCl, 1 mM TCEP) and then eluted with HB buffer (50
mM HEPES PH 8.0, 1 M KCl, 1 mM TCEP). The peak fractions were pooled and concentrated to 6.7
mg/mL (384 mM) with ~ 20% labelling efficiency.
Hydrogen/deuterium exchange mass spectrometry (HDX-MS)
A protein alone or a protein/lipid stock solution consisting of either 7.5 mM complex I or complex II
with or without 2.2 mg/mL LUVs [18% Liver PI, 10% DOPS, 17% DOPE and 55% DOPC in LUV Buffer
(25 mM HEPES pH 7.0, 100 mM NaCl and1 mM EGTA)] was incubated for 10 min at room tempera-
ture. An aliquot of 5 mL of this stock solution was mixed with 45 mL of D2O Buffer [consisting of 20
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mM HEPES pH 8.0, 300 mM NaCl, 0.5 mM TCEP, 1 mg/mL LUVs (added from a 5 mg/mL LUV stock
in LUV Buffer) and 74.6% D2O (Acros Organics)] for a defined period of time at 23˚C. In the lipid-
free experiments, the solution contained LUV Buffer instead of LUVs. The exchange reaction was
quenched using 20 mL of ice cold 5 M guanidinium chloride and 8.4% Formic Acid, pH 1. The final
pH of the sample was 2.2. Five time-points were produced (0.3/3/30/300/3000 s), with each
exchange reaction executed in triplicate. The 0.3 s time point was obtained by carrying out an
exchange for 3 s at 4˚C, instead of 23˚C. Each sample was immediately flash-frozen in liquid nitrogen
and subsequently stored at  80˚C until analysis.
Samples were thawed and manually injected on an M-Class Acquity UPLC with HDX Manager
technology (Waters) set to maintain a constant temperature of 0.1 ˚C. Protein samples were digested
using an in-line Enzymate Immobilised Pepsin Column (Waters) at 15 ˚C for two minutes, and were
collected on a van-guard pre-column trap (Waters). Peptides were eluted from the trap onto an Acq-
uity 1.7 mm particle, 100 mm  1 mm C18 UPLC column (Waters), equilibrated in Pepsin-A buffer
(0.1% formic acid), using a 5–36% gradient of Pepsin-B buffer (0.1% formic acid, 99.9% acetonitrile)
over 20 min. Peptide Data were collected using a Waters Synapt G2 Si (Waters) over a 50 to 2000
m/z range using the High-Definition MSe data acquisition mode fitted with an ESI source.
Peptide identification was conducted using the ProteinLynx Global Server (PLGS, Waters, U.K.).
Peptides were identified from three non-deuterated samples for complex I and for complex II. Deu-
terated peptides were analysed using DynamX 3.0 software (Waters, U.K.). Peptide inclusion criteria
was a minimum intensity of 5000, a minimum sequence length of 5 amino acids, a minimum of 0.1
products per amino acid, a maximum MH+ error of 5 ppm, and a positive identification meeting
these criteria in at least 2 of the three non-deuterated files. An initial automated spectral processing
step was conducted by DynamX followed by a manual inspection of individual peptides for sufficient
quality. A table of all peptides included in the analysis and their quality assessment statistics are
available in the Supplementary files 4 and 5. The HDX analysis in this manuscript complies with the
community agreed guidelines (Masson et al., 2019).
SEC-MALS
The molecular masses of human complexes I and II were determined in solution using size exclusion
chromatography coupled to multi-angle light scattering (SEC-MALS). Measurements were per-
formed using a Wyatt Heleos II 18 angle light scattering instrument coupled to a Wyatt Optilab rEX
online refractive index detector. Samples for analysis (human complex I at 1 mg/mL) and complex II
(0.8 mg/mL) were resolved on a Superose 6 10/300 analytical gel filtration column (GE Healthcare)
coupled to an Agilent 1200 series LC system running at 0.5 mL/min before then passing through the
light scattering and refractive index detectors in a standard SEC-MALS format. Protein concentration
was determined from the excess differential refractive index based on 0.186 DRI for 1 g/mL or with
the sequence based UV extinction coefficient determined in ProtParam. The measured protein con-
centration and scattering intensity were used to calculate molecular mass from the intercept of a
Debye plot using Zimm’s model as implemented in the Wyatt ASTRA software.
The experimental setup was verified using a BSA standard run with the same sample volume. The
monomer peak was used to check mass determination and to evaluate interdetector delay volumes
and band broadening parameters that were subsequently applied during analysis of complexes I
and II.
Confocal microscopy macro
The mean intensity for each label on the GUVs’ membranes was extracted using a custom ImageJ
macro. The rings corresponding to the 2D section of the GUVs were segmented by applying a
threshold to the response of a difference of a Gaussian filter applied for each channel and at each
time point. The logical union of the masks of the two segmented channels was then computed in
order to obtain a unique mask for each time point. After smoothing, the inner part of the rings was
filled and an internal morphological gradient provided the contours of the GUVs with a calibrated
thickness. Finally, the membrane of the GUVs are obtained as the intersection of these thick con-
tours and the original segmentation, allowing to discard any potential spurious signal within the
GUVs. Within a set of manually selected regions of interest, the mean intensities of the signal in the
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segmented membranes for each channels and time points were recorded and assigned to the corre-
sponding region thus circumventing the problem of tracking possibly complex regions.
Lipid mixtures
All GUV and LUV lipid mixtures are described in Supplementary files 1 and 2.
Plasmids
All plasmids are described in Supplementary file 6.
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